Organization:
Peloton Partnering, SP
First Name:
Chris
Last Name:
Dippel
Country:
United States
E-mail:
cdippel@verizon.net
Phone:
6173253550
Statement:
To have a meaningful impact on TB, drug candidates must result in approved, registered, and manufactured drugs; hence the Working Group needs an understanding and expertise in the drug commercialization process. I have that expertise and would like to work with existing Members with similar expertise and interests to form a commercialization subgroup.